Closing gaps through innovation in the tuberculosis pathology value chain

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · Published 2026-06-09 · DOI 10.1016/j.jctube.2026.100623

Free full text

Authors (4)

Anura David, Lesley Scott, Pedro da Silva, Wendy Stevens

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

David, A., Scott, L., Silva, P., et al. (2026). Closing gaps through innovation in the tuberculosis pathology value chain. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. https://doi.org/10.1016/j.jctube.2026.100623

Related articles

• Developing an integrated medication event monitoring system and smartphone-based ecological momentary assessment delivery platform to identify real-time factors influencing TB treatment adherence in South Africa · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Performance of the BACES model in a Dutch cohort with nontuberculous mycobacterial pulmonary disease · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Epidemiological trajectories and predictive modeling of latent tuberculosis prevalence in South Asia: an in-depth global burden of disease analysis (1990–2021) with advanced forecasting to 2050 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Serum tuberculosis biomarkers and their association with clinical characteristics among hospitalized adults living with HIV in Uganda · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Efficacy and safety of an intravenous amikacin-containing regimen as initial therapy in Mycobacterium avium complex pulmonary disease · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Knowledge, attitudes, and perceived barriers to tuberculosis care among patients and household contacts in Wolisso District, Oromia Region, Ethiopia · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Mycobacterium lentiflavum cutaneous pseudotumor in an immunosuppressed host · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2025 · Same journal
• Effectiveness and safety of the BPaL regimen in the Philippines · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2025 · Same journal
• Real-world challenges of 4-month rifapentine-moxifloxacin TB regimen: High hyperbilirubinemia in Thailand · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal